CYTOKINE-INDUCED INTERLEUKIN-1 RECEPTOR ANTAGONIST RELEASE IN MONONUCLEAR PHAGOCYTES

被引:18
|
作者
MARSH, CB [1 ]
WEWERS, MD [1 ]
机构
[1] OHIO STATE UNIV,DIV PULM & CRIT CARE MED,COLUMBUS,OH 43210
关键词
D O I
10.1165/ajrcmb.10.5.8179914
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
IL-1ra has recently been shown to suppress both cytokine- and endotoxin-induced IL-1beta and TNF-alpha release from monocytes. Given that mononuclear phagocytes can produce both the proinflammatory cytokines IL-1alpha, IL-1beta, and TNF-alpha as well as the suppressive cytokine IL-1ra, we proposed that IL-1alpha, IL-1beta, and TNF-alpha may induce IL-1ra from mononuclear phagocytes. To test this hypothesis, human mononuclear cells were stimulated for 18 h with IL-1alpha, IL-1beta, or TNF-alpha, and the supernatants assayed for IL-1ra by ELISA. Each cytokine induced IL-1ra secretion in a dose-response manner. However, IL-1alpha and IL-1beta were better inducers of IL-1ra than was TNF-alpha. IL-1alpha or IL-1beta at a dose of 10 ng/ml induced 3 to 6 ng/ml of IL-1ra, while TNF-alpha at a dose of 100 ng/ml stimulated only 1.4 ng/ml of IL-1ra. This induction was not due to endotoxin, as all cytokines contained less than 10 pg/ml of contaminating LPS. Furthermore, for IL-1beta-induced IL-1ra, immunoprecipitation of IL-1beta with an anti-IL-1beta antibody, but not a preimmune antibody, blocked the induction of IL-1ra. In contrast to mononuclear phagocytes, IL-1alpha, IL-1beta, and TNF-alpha did not induce further IL-1ra production in alveolar macrophages. This lack of macrophage responsiveness may relate to the constitutive production of IL-1ra by these mature mononuclear phagocytes. Together, these findings suggest that IL-1alpha, IL-1beta, and TNF-alpha from blood mononuclear cells may induce negative feedback on proinflammatory cytokine production by up-regulating IL-1ra.
引用
收藏
页码:521 / 525
页数:5
相关论文
共 50 条
  • [31] Interleukin-1 and interleukin-1 receptor antagonist in systemic lupus erythematosus
    Chang, DM
    IMMUNOLOGICAL INVESTIGATIONS, 1997, 26 (5-7) : 649 - 659
  • [32] INTERLEUKIN-1 RECEPTOR ANTAGONIST - A NEW MEMBER OF THE INTERLEUKIN-1 FAMILY
    AREND, WP
    JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05): : 1445 - 1451
  • [33] INTERLEUKIN-1 RECEPTOR ANTAGONIST ACTIVITY OF A HUMAN INTERLEUKIN-1 INHIBITOR
    HANNUM, CH
    WILCOX, CJ
    AREND, WP
    JOSLIN, FG
    DRIPPS, DJ
    HEIMDAL, PL
    ARMES, LG
    SOMMER, A
    EISENBERG, SP
    THOMPSON, RC
    NATURE, 1990, 343 (6256) : 336 - 340
  • [34] Predictors of interleukin-1β and interleukin-1 receptor antagonist in infant saliva
    Miller, Elizabeth M.
    AMERICAN JOURNAL OF HUMAN BIOLOGY, 2021, 33 (03)
  • [35] INTERLEUKIN-1 RECEPTOR ANTAGONIST INHIBITS THE HYPERCALCEMIA MEDIATED BY INTERLEUKIN-1
    GUISE, TA
    GARRETT, IR
    BONEWALD, LF
    MUNDY, GR
    JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 (05) : 583 - 587
  • [36] Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease
    Cominelli, F
    Pizarro, TT
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 : 49 - 53
  • [37] Localisation of mRNA for interleukin-1 receptor and interleukin-1 receptor antagonist in the rat ovary
    Wang, LJ
    Brannstrom, M
    Cui, KH
    Simula, AP
    Hart, RP
    Maddocks, S
    Norman, RJ
    JOURNAL OF ENDOCRINOLOGY, 1997, 152 (01) : 11 - 17
  • [38] Immunoglobulin D enhances the release of tumour necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells
    Drenth, JPH
    Goertz, J
    Daha, MR
    vanderMeer, JWM
    IMMUNOLOGY, 1996, 88 (03) : 355 - 362
  • [39] INTERLEUKIN-1 RECEPTOR ANTAGONIST COMPETITIVELY INHIBITS THE BINDING OF INTERLEUKIN-1 TO THE TYPE-II INTERLEUKIN-1 RECEPTOR
    GRANOWITZ, EV
    CLARK, BD
    MANCILLA, J
    DINARELLO, CA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (22) : 14147 - 14150
  • [40] Interleukin-1 receptor antagonist synthesis by peripheral blood mononuclear cells in hemodialysis patients
    Balakrishnan, VS
    Jaber, BL
    Natov, SN
    Cendoroglo, M
    King, AJ
    Schmid, CH
    Pereira, BJG
    KIDNEY INTERNATIONAL, 1998, 54 (06) : 2106 - 2112